Skip to main content
. 2022 Aug 20;29(8):5933–5941. doi: 10.3390/curroncol29080468

Figure 4.

Figure 4

Nine-month follow-up FDG-TEP scan after introduction of imatinib, showing disease progression with new liver metastasis.